Wu J J, Lark M W, Chun L E, Eyre D R
Department of Orthopaedics, University of Washington, Seattle 98195.
J Biol Chem. 1991 Mar 25;266(9):5625-8.
Human recombinant stromelysin-1 was shown to cleave four types of collagen (types II, IX, X, and XI) prepared from bovine and rat cartilages at specific sites. Stromelysin-1 cleaved salt-soluble native molecules of type IX collagen into two main triple-helical fragments, COL1 and COL2,3. Protein microsequencing identified the exact cleavage sites in the NC2 domain of all three chains, alpha 1(IX), alpha 2(IX), and alpha 3(IX). Stromelysin-1 also acted as a "telopeptidase," in that it efficiently clipped intact molecules of types II and XI collagens at sites just inside their terminal cross-linking hydroxylysine residues. Native molecules of type X collagen were cleaved by stromelysin-1 within their triple helical domains at a COOH-terminal site that reduced the alpha 1(X) chain size by 10 kDa. These findings suggest an important role for stromelysin in the turnover and remodeling of the collagenous matrix of cartilage both normally and in degenerative joint disease.
人重组基质溶素-1可在特定位点切割从牛和大鼠软骨制备的四种类型的胶原蛋白(II型、IX型、X型和XI型)。基质溶素-1将盐溶性天然IX型胶原蛋白分子切割成两个主要的三螺旋片段,即COL1和COL2,3。蛋白质微量测序确定了三条链α1(IX)、α2(IX)和α3(IX)在NC2结构域中的精确切割位点。基质溶素-1还可作为一种“端肽酶”,因为它能在II型和XI型胶原蛋白完整分子的末端交联羟赖氨酸残基内侧的位点有效地进行切割。X型胶原蛋白的天然分子在其三螺旋结构域内的一个COOH末端位点被基质溶素-1切割,使α1(X)链大小减少10 kDa。这些发现表明,基质溶素在正常和退行性关节疾病中软骨胶原基质的周转和重塑中起着重要作用。